SEMA3A and myeloid sarcoma: As semaphorins are re-expressed after demyelination in mouse, similarly to in human MS lesions, we hypothesized that manipulation of the levels of Sema3A or 3F to a demyelinated lesion would alter OPC recruitment and hence remyelination.